tirzepatide news 2025 New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Eli Lilly's weight loss drug

Broader metabolic coverage Metabolic syndrome involves multiple interconnected dysfunctions: insulin resistance, dyslipidemia, hypertension, visceral obesity, and chronic inflammation

Talk with your healthcare provider or registered dietitian to personalize your plan and achieve your goals.

Is it something to Worry About

Bhmt deleted mice were observed to have significantly high hepatic triglycerides and later developed hepatic tumors (Teng et al., 2011), indicating that reduced BHMT activity may increase the susceptibility to fatty liver and hepatocellular carcinoma

Noom: Weight Management allows for members to focus on improving their daily lifestyle habits, providing them with the support they need for long-lasting change, said Susan Deakin, DO, medical director and vice president, Population and Curated Health at Highmark Health and Internal Medicine physician at Allegheny Health Network